TTX-siLIN28b

N/A

Report date: 2022/09/19 14:45:21
NME

Base Information

Drug NameTTX-siLIN28b
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionProtein lin-28 homolog B modulators
TargetsProtein lin-28 homolog B
Therapy Area/IndicationsPancreatic NeoplasmsLiver NeoplasmsStomach Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTransCode Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTransCode Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsLiver NeoplasmsStomach Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A